|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | NSC125066 sulfate | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||||||
| 化学式 | C55H85N17O25S4 |
||||||||||
| 分子量 | 1512.62 | CAS No. | 9041-93-4 | ||||||||
| Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (66.11 mM) | ||||||||
| Water | 100 mg/mL (66.11 mM) | ||||||||||
| Ethanol | Insoluble | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | ブレオマイシン硫酸塩 (Bleomycin Sulfate (NSC125066)) はグリコペプチド系抗生物質であり、また扁平上皮癌 (SCC) に対する抗がん活性物質でもあります。UT-SCC-19A 細胞における IC50 は 4 nM です。 |
|---|---|
| in vitro | UT-SCC-12A and UT-SCC-12B are both more resistant to Bleomycin sulfate with IC50 of 14.2 nM and 13 nM, respectively. [1] Alveolar macrophages incubated with 0.01 μg/mL to 1μg /mL this compound for 18 hours secretes significantly more fibroblast growth factor than macrophages incubated without this chemical. Macrophages stimulated with this compound continues to produce significant amounts of fibroblast growth factor even after this chemical is removed and replaced with fresh (Bleomycin sulfate-free) media. Fibroblast growth factor secretion by this compound-stimulated alveolar macrophages is inhibited by cycloheximide, and the 5-lipoxygenase inhibitors NDGA (nordihydroguaiaretic acid) and BW755c, indicating not only a requirement for protein synthesis but also for metabolites of the 5-lipoxygenase pathway of arachidonic acid metabolism for full expression of activity. [2] This chemical (400 µg/mL) incubation for 24 hours decreases the viability of NTera-2 cells, and increases caspase-3, -8 and -9 activities, Bax and cytoplasmic cytochrome c levels and decreases Bcl-2 levels. [3] In terms of unstable aberrations, the clastogenic effect of this compound on ADIPO-P2 cells persists for at least 10 days after exposure. This chemical-induced telomere instability in mammalian cells persists for several generations after exposure. Moreover, the appearance of telomere fusions in this compound-exposed cells 10 days after treatment suggests that this chemical can induce delayed telomere instability. [4] |
| in vivo | Day 7 post-Bleomycin sulfate, CD45+ cells in BALf in NOX-/- is 1.7-fold > WT, 57% of which are Mf that decreases by 67% in WT and 83% in NOX-/- by Day 21. [5] |
| 細胞アッセイ | 細胞株 | ADIPO-P2 cells |
|---|---|---|
| 濃度 | 2.5 μg/mL | |
| 反応時間 | 30 minutes | |
| 実験の流れ | ADIPO-P2 cells are grown in D-MEM high glucose medium supplemented with 20% fetal calf serum, penicillin (100 U/mL) and streptomycin (100 μg/mL) at 37 °C and 5% CO2 atmosphere. Cells are cultured as monolayer in TC25 Corning flasks containing 1.5 × 105 cells/mL. For each experiment, two flasks are set up, one for the control and one for the treated culture. During the log phase of growth ADIPO-P2 cells are treated with a 30 minutes pulse of 2.5 μg/mL of Bleomycin sulfate. Control cultures are set up in parallel but not exposed to this compound. Time of exposure and concentration of this chemical are chosen according to previous studies carried out in our laboratory with mammalian cells exposed to it. At the end of the pulse treatment with this compound, the cells are washed twice with Hank's balanced salt solution and kept in culture with fresh culture medium until harvesting. Cells are continuously maintained in culture during 5 passages or subcultures after treatment. Subcultivation is carried out whenever the cultures became confluent (approximately 4 × 105 cells/mL of culture medium). To estimate cell growth, at the time of subcultivation cells are collected by trypsinization, an aliquot of about 200 μL stained with 0.4% trypan blue, and the number of viable cells is determined. Cells are then suspended in fresh culture medium and dispensed into new culture flasks containing 1 × 105 cells/mL to continue growing. The rest of the cells is discarded or dispensed in another flask for cytogenetic analysis, which is performed at 18 hours and 10 days after the end of treatments. To analyze chromosomal aberrations, colchicine (0.1 μg/mL) is added to cell cultures during the last 3 hours of culture. Chromosome preparations are made following standard procedures. After harvesting, cells are hypotonically shocked, fixed in methanol:acetic acid (3:1), spread onto glass slides and processed for PNA-FISH. Two independent experiments are carried out. |
|
| 動物実験 | 動物モデル | CD-1 mice |
| 投薬量 | 5 mg/kg, 2 ml/kg | |
| 投与方法 | Administered via i.t. |
|

Data from [Data independently produced by AACRElizabeth williamson from university of florida. , 2011]
| Nuclear pores safeguard the integrity of the nuclear envelope [ Nat Cell Biol, 2025, 10.1038/s41556-025-01648-3] | PubMed: 40205196 |
| S1PR1-biased activation drives the resolution of endothelial dysfunction-associated inflammatory diseases by maintaining endothelial integrity [ Nat Commun, 2025, 16(1):1826] | PubMed: 39979282 |
| The CCL20-integrin α5β1 interaction enhances TGF-β/Smad signaling to promote fibroblast activation in pulmonary fibrosis [ Nat Commun, 2025, 16(1):9183] | PubMed: 41102188 |
| Senescent Fibroblasts Drive FAP/OLN Imbalance Through mTOR Signaling to Exacerbate Inflammation and Bone Resorption in Periodontitis [ Adv Sci (Weinh), 2025, 12(7):e2409398] | PubMed: 39716898 |
| Histone methyltransferase KMT2A promotes pulmonary fibrogenesis via targeting pro-fibrotic factor PU.1 in fibroblasts [ Clin Transl Med, 2025, 15(2):e70217] | PubMed: 39888275 |
| Inhibition of 11β-hydroxysteroid dehydrogenase 1 alleviates pulmonary fibrosis through inhibition of endothelial-to-mesenchymal transition and M2 macrophage polarization by upregulating heme oxygenase-1 [ Cell Death Dis, 2025, 16(1):196] | PubMed: 40118823 |
| CITK modulates BRCA1 recruitment at DNA double strand breaks sites through HDAC6 [ Cell Death Dis, 2025, 16(1):320] | PubMed: 40254670 |
| 13-Methylpalmatine alleviates bleomycin-induced pulmonary fibrosis by suppressing the ITGA5/TGF-β/Smad signaling pathway [ Phytomedicine, 2025, 140:156545] | PubMed: 40023972 |
| Exercise improves pulmonary fibrosis and neurological symptoms via S100A12 inhibition [ Front Immunol, 2025, 16:1583827] | PubMed: 40655156 |
| Electrochemotherapy with bleomycin, oxaliplatin, or cisplatin in mouse tumor models, from tumor ablation to in situ vaccination [ Front Immunol, 2025, 16:1470432] | PubMed: 40007542 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。